MedTrace Logo

Clinical Evaluation of the FluidVision Accommodating Intraocular Lens (AIOL)

NCT02049567 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 170

Last updated 2021-05-21

No results posted yet for this study

Summary

The purpose of this study is to evaluate the safety and effectiveness of an investigational IOL.

Conditions

  • Aphakia

Interventions

DEVICE

FluidVision AIOL

Investigational implantable medical device intended for long-term use over the lifetime of the cataract subject

PROCEDURE

Cataract Surgery

Performed using standard microsurgical techniques

Sponsors & Collaborators

  • PowerVision

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
DEVICE_FEASIBILITY
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-14
Primary Completion
2015-06-24
Completion
2017-11-06
FDA Device
Yes

Countries

  • Germany
  • South Africa

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02049567 on ClinicalTrials.gov